Earnings Report Ahead of Market Opening for November 7, 2025: CEG, KKR, ENB, DUK, BAM, TU, BIP, CNH, BEN, FLR, ESNT, MKTX
Earnings Reports Overview: Several companies, including Constellation Energy, KKR, and Duke Energy, are set to report their earnings for the quarter ending September 30, 2025, with varying forecasts and performance expectations.
Performance Expectations: Constellation Energy is expected to see a 10.95% increase in earnings per share, while KKR and Enbridge anticipate decreases of 2.54% and 2.50%, respectively.
Price to Earnings Ratios: Most companies, such as Duke Energy and Brookfield Asset Management, are projected to have higher Price to Earnings ratios compared to their industry averages, indicating potential for greater earnings growth.
Analyst Consensus: The consensus earnings forecasts show mixed results, with some companies like Brookfield Infrastructure Partners expecting increases, while others like CNH Industrial are facing significant declines in earnings per share.
Trade with 70% Backtested Accuracy
Analyst Views on KKR
About KKR
About the author


- Stake Sale Plan: Bain Capital is looking to sell at least a 40% stake in Bridge Data Centres, which would value the Singapore-based data infrastructure builder at $5 billion, reflecting strong market interest in the data center sector.
- Investment Banks Involved: Bain has hired Citigroup and JPMorgan to manage the sale, which has attracted interest from several private equity and infrastructure funds, indicating a rising demand for data center assets in the market.
- Surging Market Demand: The booming demand for cloud computing, artificial intelligence, and digital services has made data center assets the most sought-after infrastructure investments in Asia, with global M&A deals in this sector projected to reach $98 billion by 2025.
- Historical Context: Founded a decade ago, Bridge Data Centres was merged with Bain Capital and listed on Nasdaq in 2020, later privatized in 2023 for $3.16 billion, underscoring its significant position in the rapidly evolving data center market.
- Strategic Investment: KKR's $1.5 billion equity investment in Vertical Bridge marks its entry as a new strategic investor, aimed at supporting the company's future growth initiatives.
- Capital Structure Optimization: This investment establishes a fully funded long-term capital structure for Vertical Bridge, ensuring ample financial support for its ongoing development.
- Asset Portfolio Expansion: Vertical Bridge currently owns and operates over 17,000 communications towers, and this investment will further enhance its market position and operational capabilities nationwide.
- Market Outlook: KKR's investment not only secures funding for Vertical Bridge but also reflects confidence in the ongoing growth potential of the communications infrastructure sector, expected to boost the company's competitive edge in the industry.
- Capital Structure Optimization: KKR's $1.5 billion equity investment in Vertical Bridge establishes a fully funded long-term capital structure that supports the company's strategic plan to operate over 17,000 towers nationwide, enhancing its market position.
- Growth Strategy Reinforcement: CEO Ron Bizick stated that this transaction provides the resources necessary for the company to scale its portfolio while maintaining a disciplined, returns-focused capital deployment strategy, ensuring ongoing market competitiveness.
- Rising Infrastructure Demand: KKR's Global Head of Digital Infrastructure, Waldemar Szlezak, highlighted that the densification of 5G and surging data demand are creating a structural need for higher quality wireless infrastructure, which Vertical Bridge is well-positioned to meet with its high-quality tower platform and strong execution track record.
- Long-term Partnership: The participation of existing investors DigitalBridge and La Caisse in this investment underscores their confidence in Vertical Bridge's long-term growth potential, further solidifying the company's leadership position in the communications infrastructure sector.
- Equity Loss: Thoma Bravo and its co-investors, who acquired Medallia for $6.4 billion in 2021, are nearing a deal to hand the company over to lenders, which is expected to erase $5.1 billion in equity, highlighting the severity of the investment failure.
- Debt Pressure: Medallia is burdened with $3 billion in debt owed to Apollo, Blackstone, KKR, and Antares Capital, exacerbating its financial difficulties and impacting operational capabilities.
- Market Reaction: Although Thoma Bravo, Blackstone, and KKR declined to comment, the market is rife with uncertainty regarding Medallia's future, which could lead to diminished investor confidence and negatively affect its stock performance.
- Industry Impact: This transaction may prompt a reevaluation of the risks associated with private equity firms in high-leverage acquisitions, particularly in an uncertain economic environment, potentially influencing the structure and execution of similar deals in the future.
- Royalty Agreement Established: HealthCare Royalty (HCRx) has entered into a royalty monetization agreement with former Oncoceutics shareholders for an undisclosed percentage of royalties on Modeyso® (dordaviprone) commercial sales, indicating HCRx's commitment to new treatment options that could generate significant revenue.
- FDA Approval Context: Modeyso received U.S. FDA accelerated approval in August 2025 for treating patients aged one year and older with diffuse midline glioma harboring an H3 K27M mutation, addressing a critical unmet medical need and potentially increasing HCRx's market share.
- Strong Early Market Performance: Since its launch in August, Modeyso has demonstrated robust early performance, reflecting the urgent demand for treatment among patients with H3 K27M-mutant diffuse midline glioma, which will further enhance HCRx's competitiveness in the biopharmaceutical sector.
- Strategic Investment Implications: HCRx's CEO Clarke Futch noted that the addition of Modeyso will provide significant benefits to patients lacking approved treatment options, showcasing the company's ongoing commitment to biopharmaceutical innovation and potentially driving future business growth.
- Restructuring Negotiations: Private equity firm Thoma Bravo is nearing an agreement to transfer troubled software company Medallia to its lenders, concluding months of restructuring talks, which highlights the company's difficult financial situation.
- Significant Equity Loss: This move will wipe out $5.1 billion in equity for Thoma Bravo and its co-investors, reflecting a substantial loss from their $6.4 billion acquisition of Medallia in 2021, indicating a poor investment decision.
- Heavy Debt Burden: Medallia is currently struggling under $3 billion in debt owed to major creditors including Blackstone, KKR, and Apollo, showcasing its vulnerable position in a competitive market.
- Lack of Market Confidence: Both Thoma Bravo and KKR declined to comment on the matter, while Apollo and Medallia did not respond to media inquiries, suggesting a lack of confidence and interest from the market regarding this transaction.










